179 related articles for article (PubMed ID: 8683040)
1. Protection of C3H/HE J mice from development of Candida albicans infection by oral administration of Juzen-taiho-to and its component, Ginseng radix: possible roles of macrophages in the host defense mechanisms.
Akagawa G; Abe S; Tansho S; Uchida K; Yamaguchi H
Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):73-89. PubMed ID: 8683040
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of oral administration of a traditional medicine, Juzen-Taiho-To, and its components on lethal Candida albicans infection in immunosuppressed mice.
Abe S; Tansho S; Ishibashi H; Inagaki N; Komatsu Y; Yamaguchi H
Immunopharmacol Immunotoxicol; 1998 Aug; 20(3):421-31. PubMed ID: 9736446
[TBL] [Abstract][Full Text] [Related]
3. Acidic polysaccharides from rhizomes of Atractylodes lancea as protective principle in Candida-lnfected mice.
Inagaki N; Komatsu Y; Sasaki H; Kiyohara H; Yamada H; Ishibashi H; Tansho S; Yamaguchi H; Abe S
Planta Med; 2001 Jul; 67(5):428-31. PubMed ID: 11488456
[TBL] [Abstract][Full Text] [Related]
4. Low dose of Concanavalin-A enhances innate immune response and prevents liver injury in mice infected with Candida albicans.
Conchon-Costa I; Loyola W; Gaziri LC; Custódio LA; Felipe I
FEMS Immunol Med Microbiol; 2007 Apr; 49(3):330-6. PubMed ID: 17284281
[TBL] [Abstract][Full Text] [Related]
5. Protection of immunosuppressed mice from lethal Candida infection by oral administration of a kampo medicine, hochu-ekki-to.
Abe S; Tansho S; Ishibashi H; Akagawa G; Komatsu Y; Yamaguchi H
Immunopharmacol Immunotoxicol; 1999 May; 21(2):331-42. PubMed ID: 10319284
[TBL] [Abstract][Full Text] [Related]
6. The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis.
Netea MG; Van Der Graaf CA; Vonk AG; Verschueren I; Van Der Meer JW; Kullberg BJ
J Infect Dis; 2002 May; 185(10):1483-9. PubMed ID: 11992285
[TBL] [Abstract][Full Text] [Related]
7. Influence of leflunomide on gastrointestinal Candida albicans infection induced in naive and arthritic newborn mice.
Dimitrova P; Ivanovska N
Int Immunopharmacol; 2006 Nov; 6(11):1682-9. PubMed ID: 16979122
[TBL] [Abstract][Full Text] [Related]
8. [Protective effect of oral administration of several traditional Kampo-medicines on lethal Candida infection in immunosuppressed mice].
Abe S; Ishibashi H; Tansho S; Hanazawa R; Komatsu Y; Yamaguchi H
Nihon Ishinkin Gakkai Zasshi; 2000; 41(2):115-9. PubMed ID: 10777823
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-dependent candidacidal mechanisms in the murine system. Comparison of murine Kupffer cell and peritoneal macrophage candidacidal mechanisms.
Redmond HP; Shou J; Gallagher HJ; Kelly CJ; Daly JM
J Immunol; 1993 Apr; 150(8 Pt 1):3427-33. PubMed ID: 8385685
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of an extract of North American ginseng (Panax quinquefolius L.) in Candida albicans-infected complement-deficient mice.
Trammell RA; Cox L; Pikora J; Murphy LL; Toth LA
J Ethnopharmacol; 2012 Jan; 139(2):414-21. PubMed ID: 22138349
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral administration of a pectic polysaccharide fraction from a kampo (Japanese herbal) medicine "juzen-taiho-to" on antibody response of mice.
Kiyohara H; Matsumoto T; Takemoto N; Kawamura H; Komatsu Y; Yamada H
Planta Med; 1995 Oct; 61(5):429-34. PubMed ID: 7480204
[TBL] [Abstract][Full Text] [Related]
12. Juzentaihoto, a Kampo medicine, enhances IL-12 production by modulating Toll-like receptor 4 signaling pathways in murine peritoneal exudate macrophages.
Chino A; Sakurai H; Choo MK; Koizumi K; Shimada Y; Terasawa K; Saiki I
Int Immunopharmacol; 2005 May; 5(5):871-82. PubMed ID: 15778123
[TBL] [Abstract][Full Text] [Related]
13. [Chemical characterization and biological activity of the immunologically active substances in Juzen-taiho-to (Japanese kampo prescription)].
Yamada H
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1500-5. PubMed ID: 2786380
[TBL] [Abstract][Full Text] [Related]
14. LAAE-14, a new anti-inflammatory drug, increases the survival of Candida albicans-inoculated mice.
Lucas R; Villamón E; Payá M; Alves M; del Olmo E; Gozalbo D; Gil ML
FEMS Immunol Med Microbiol; 2004 Apr; 40(3):239-42. PubMed ID: 15039100
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
Khan MA; Khan A; Owais M
FEMS Immunol Med Microbiol; 2006 Feb; 46(1):63-9. PubMed ID: 16420598
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory effects of Aloe vera and its fractions on response of macrophages against Candida albicans.
Farahnejad Z; Ghazanfari T; Yaraee R
Immunopharmacol Immunotoxicol; 2011 Dec; 33(4):676-81. PubMed ID: 21401385
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary defence mechanism in mice. A comparative role of alveolar macrophages and polymorphonuclear cells against infection with Candida albicans.
Lal S; Mitsuyama M; Miyata M; Ogata N; Amako K; Nomoto K
J Clin Lab Immunol; 1986 Mar; 19(3):127-33. PubMed ID: 3519975
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of granulocyte/macrophage colony-stimulating factor (GM-CSF) in enhancing macrophage resistance to Legionella pneumophila vs Candida albicans.
Yamamoto Y; Klein TW; Tomioka M; Friedman H
Cell Immunol; 1997 Feb; 176(1):75-81. PubMed ID: 9070320
[TBL] [Abstract][Full Text] [Related]
19. Contribution of cytokines to time-dependent augmentation of resistance against Listeria monocytogenes after administration of a traditional Chinese medicine, xiao-chai-hu-tang (Japanese name: shosaiko-to).
Kawakita T; Mitsuyama M; Kumazawa Y; Miura O; Yumioka E; Nomoto K
Immunopharmacol Immunotoxicol; 1989; 11(2-3):233-55. PubMed ID: 2516094
[TBL] [Abstract][Full Text] [Related]
20. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans.
Netea MG; van Tits LJ; Curfs JH; Amiot F; Meis JF; van der Meer JW; Kullberg BJ
J Immunol; 1999 Aug; 163(3):1498-505. PubMed ID: 10415052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
